Trial | Interventions | Dose (mg/day) | Comparator | No of patients | Course (weeks) | Follow-up (weeks) | Source |
---|---|---|---|---|---|---|---|
DiaconAH 2009,2012 | Bedaquiline | 1600,1200 | placebo | 47 | 8 | 104 | |
Trail NCT00449644 | Bedaquiline | 1600,1200 | placebo | 160 | 24 | 104 | clinical trial website [24], study register |
Gler MT 2012 | Delamanid | 400,200 | placebo | 481 | 8 | 104 | |
Trial NCT00685360 | Delamanid | 400,200 | placebo | 192 | 8 | 104 | journal article [27], |
Zhang Q 2013 | Delamanid | 400,200 | placebo | 38 | 24 | 104 | journal article [28] |
Carroll MW 2013 | Metronidazole | 1500 | placebo | 35 | 8 | 24 | journal article [29] |
Trail NCT00425113 | Metronidazole | 1500 | placebo | 35 | 8 | 72 | clinical trial website [30] |
Trail NCT00082173 | Moxifloxacin | 400 | placebo | 146 | 8 | 0 | clinical trial website [31] |
Chen Y 2013 | Moxifloxacin | 400 | placebo | 74 | 52 | 0 | journal article [32] |
Koh WJ 2013 | Moxifloxacin | 400 | levofloxacin | 90 | 12 | 0 | |
Liang LL 2011 | Moxifloxacin | 400 | levofloxacin | 46 | 72 | 0 | journal article [35] |
Koh WJ 2013 | Levofloxacin | 750 | moxifloxacin | 92 | 12 | 0 | |
Liang LL 2011 | Levofloxacin | 600 | moxifloxacin | 36 | 72 | 0 | journal article [35] |